CRISPR Base Editing for a Monogenic Liver Disorder: Off-Target Assessment and Long-Term Follow-Up Obligations. (2024). Translational Medicine & Therapeutics Journal, 3(2), 74-82. https://doi.org/10.5281/zenodo.22649285